Jazz Pharmaceuticals plc
JAZZ· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|
| Revenue | $235.77M | $183.70M | $83.54M | $83.54M |
| Net Income | $55.29M | $200.55M | $37.47M | $37.47M |
| EPS Diluted | $0.90 |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| $3.28 |
| $0.79 |
| $0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.